Jeil Pharmaceutical Co.,Ltd

A271980

KR7271980005

Pharmaceuticals

End-of-day quote Korea S.E. Other stock markets 03:30:00 17/07/2024 am IST			5-day change	1st Jan Change
15,890 ^KRW	+1.73%		+2.32%	-7.08%

16/05	Jeil Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
2023	Jeil Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	CI

Jeil Pharmaceutical Co.,Ltd's Equity Buyback Plan Extended till December 09, 2021.

June 09, 2021

On June 09, 2021, the company announced that it has extended its plan duration till December 09, 2021.

Latest news about Jeil Pharmaceutical Co.,Ltd

Jeil Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	16/05	CI
Jeil Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	12/23/12	CI
Tranche Update on Jeil Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on December 10, 2020.	13/22/13	CI
Tranche Update on Jeil Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on December 10, 2020.	13/22/13	CI
Tranche Update on Jeil Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on December 10, 2020.	13/22/13	CI
Tranche Update on Jeil Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on December 10, 2020.	13/22/13	CI
Tranche Update on Jeil Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on December 10, 2020.	13/22/13	CI
Jeil Pharmaceutical Co.,Ltd's Equity Buyback announced on December 10, 2020, has expired with 42,941 shares, representing 0.29% for KRW 1,521.88 million.	09/22/09	CI
Jeil Pharmaceutical Co.,Ltd's Equity Buyback Plan Extended till December 9, 2022.	09/22/09	CI
Rockwell Medical Announces Regulatory Approval of Triferic® AVNU in South Korea	13/22/13	CI
Jeil Pharmaceutical Co.,Ltd's Equity Buyback Plan Extended till June 9, 2022.	09/21/09	CI
Jeil Pharmaceutical Co.,Ltd's Equity Buyback announced on December 10, 2020, has expired.	09/21/09	CI
Jeil Pharmaceutical Co.,Ltd's Equity Buyback Plan Extended till December 09, 2021.	09/21/09	CI
Rockwell Medical, Inc. Announces Submission of Triferic® New Drug Application in South Korea by Partner, Jeil Pharmaceutical Co., Ltd	01/21/01	CI
Jeil Pharmaceutical Co.,Ltd announces an Equity Buyback for KRW 3,000 million worth of its shares.	10/20/10	CI
Jeil Pharmaceutical Co.,Ltd authorizes a Buyback Plan.	10/20/10	CI
Tranche Update on Jeil Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on May 16, 2019.	15/20/15	CI
Jeil Pharmaceutical Co.,Ltd's Equity Buyback announced on May 16, 2019, has expired with 84,920 shares, representing 0.58% for KRW 2,707.67 million.	15/20/15	CI
Jeil Pharmaceutical Co.,Ltd announces an Equity Buyback for KRW 3,000 million worth of its shares.	16/19/16	CI
Jeil Pharmaceutical Co.,Ltd authorizes a Buyback Plan.	16/19/16	CI
Jeil Pharma Holdings Inc completed the acquisition of additional 35.2% stake in Jeil Pharmaceutical Co.,Ltd for approximately KRW 250 billion.	16/18/16	CI
Jeil Pharma Holdings Inc made an offer to acquire an additional 47.6% stake in Jeil Pharmaceutical Co.,Ltd for approximately KRW 490 billion.	02/18/02	CI
Jeil Pharma Holdings Inc acquired 13.53% stake in Jeil Pharmaceutical Co.,Ltd.	02/18/02	CI
Jeil Pharmaceutical Co.,Ltd(KOSE:) added to S&P Global BMI Index	17/17/17	CI
Jeil Pharmaceutical Co., Ltd. announced the spin-off of its pharmaceuticals manufacturing and sales business.	16/17/16	CI

Chart Jeil Pharmaceutical Co.,Ltd

Duration

Period

More charts

JEIL PHARMACEUTICAL CO.,LTD is a Korea-based company principally engaged in the manufacturing and distribution of pharmaceuticals. The Company provides anti-inflammatory painkillers, anticancer drugs, gastritis drugs, antibiotics, ulcer treatments, antidepressant drugs, pollakisuria and incontinence treatments, impetigo drugs, septicemia treatments, hyperlipidemia treatments, peripheral neuropathic pain drugs, hypertension drugs and others. The Company distributes its products within domestic market and to overseas markets.

Sector

Pharmaceuticals

Calendar

09/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
JEIL PHARMACEUTICAL CO.,LTD	-7.08%	164M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+25.40%	45.35B
OTSUKA HOLDINGS CO., LTD.	+38.38%	24.34B
SANDOZ GROUP AG	+26.57%	16.51B
CIPLA LIMITED	+21.19%	14.6B
ZYDUS LIFESCIENCES LIMITED	+71.91%	14.27B
THE MEDICINES COMPANY	-0.05%	6.79B
ONO PHARMACEUTICAL CO., LTD.	-11.63%	6.57B
ASPEN PHARMACARE HOLDINGS LIMITED	+15.08%	5.76B
STADA ARZNEIMITTEL	-8.87%	5.73B